基础医学与临床 ›› 2013, Vol. 33 ›› Issue (8): 966-970.

• 研究论文 • 上一篇    下一篇

5-Aza-CdR抑制HepG2细胞DLK1基因表达及细胞生长

黄铀新,罗耀玲,刘瑶   

  1. 赣南医学院第一附属医院
  • 收稿日期:2012-07-03 修回日期:2012-09-27 出版日期:2013-08-05 发布日期:2013-07-18
  • 通讯作者: 黄铀新 E-mail:hyx3655@gmail.com
  • 基金资助:
    肝癌中PEG10基因印记状态改变的表观遗传学机制研究

Effect of 5-Aza-CdR on DLK1 expression and the growth of the human hepatocarcinoma cell line HepG2

  • Received:2012-07-03 Revised:2012-09-27 Online:2013-08-05 Published:2013-07-18
  • Contact: You-Xin HUANG E-mail:hyx3655@gmail.com

摘要: 目的 在探讨去甲基化药物5-氮杂-2’-脱氧胞苷(5-Aza-CdR)对DLK1基因及肝癌细胞系HepG2增殖、侵袭的影响。方法 不同浓度的5-Aza-CdR 及PBS作用HepG2细胞后,RT-PCR、Western blot检测DLK1基因及蛋白的表达水平;MTT、Transwell和流式细胞术检测HepG2细胞的生长、侵袭力及细胞周期的变化。结果 HepG2细胞经5-Aza-CdR处理后,DLK1 mRNA、蛋白表达量降低;MTT试验显示细胞生长速度依5-Aza-CdR浓度出现不同程度减慢;流式结果表明G1期细胞减少,S期细胞增加,出现S期阻滞;Transwell证实侵袭能力显著降低( P< 0.05)。结论 去甲基化药物5-Aza-CdR能有效地抑制DLK1基因的表达,从而抑制肿瘤细胞HepG2生长、增殖、侵袭能力。

关键词: HepG2细胞 5-Aza-CdR DLK1基因

Abstract: Objective To investigate if demethylation drug 5-aza-2'-deoxycytidine (5-Aza-CdR) could inhibite the expression of DLK1 and cell proliferation,invasion in hepatoma cell line HepG2. Methods After different concentrations of 5-Aza-CdR was treated on HepG2 cells, RT-PCR、Western blot was used for detection of DLK1 mRNA and protein level change; MTT, Transwell and flow cytometry were used for detection of cell growth, cycle and invasiveness. Results After treatment with 5μmol/L 5-Aza-CdR, the expression of DLK1 mRNA and protein decreased,the cell growth rate slowed, the number of G1 phase cells decreased where the S phase cells increased, Transwell confirmed invasive ability decreased significantly ( P < 0.05 ). Conclusion 5-Aza-CdR can effectively inhibit DLK1 gene expression, thereby inhibiting tumor cell growth, proliferation, invasion of HepG2.

Key words: HepG2 5-Aza-CdR DLK1

中图分类号: